Moneta Group Investment Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$409K Buy
1,533
+3
+0.2% +$812 ﹤0.01% 555
2025
Q4
$384K Sell
1,530
-363
-19% -$96.4K ﹤0.01% 567
2025
Q3
$544K Sell
1,893
-483
-20% -$129K ﹤0.01% 473
2025
Q2
$624K Buy
2,376
+126
+6% +$30.7K 0.01% 391
2025
Q1
$524K Sell
2,250
-1,616
-42% -$392K 0.01% 404
2024
Q4
$886K Buy
3,866
+128
+3% +$29.4K 0.01% 300
2024
Q3
$835K Sell
3,738
-1,871
-33% -$411K 0.01% 304
2024
Q2
$1.14M Sell
5,609
-1,159
-17% -$236K 0.02% 255
2024
Q1
$1.48M Buy
6,768
+2,207
+48% +$486K 0.02% 221
2023
Q4
$1.04M Buy
4,561
+20
+0.4% +$4.2K 0.02% 236
2023
Q3
$913K Sell
4,541
-2,770
-38% -$584K 0.02% 230
2023
Q2
$1.3M Buy
+7,311
New +$1.42M 0.03% 203
2018
Q2
Sell
-524
Closed -$73K 535
2018
Q1
$73K Buy
+524
New +$77K 0.01% 287

Other funds holding LH

Moneta Group Investment Advisors's LH Position: Q1 2026 in Review

Moneta Group Investment Advisors increased its Labcorp (LH) stake by 0.2% in Q1 2026, buying an estimated $812 and bringing the position to 1,533 shares worth $409K. The position accounts for ﹤0.01% of the portfolio, ranked #555.

Moneta Group Investment Advisors first reported a position in LH in Q1 2018 and has held it in 13 quarters since. The position peaked at $1.48M in Q1 2024. 1,032 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Moneta Group Investment Advisors held 1,533 shares of Labcorp worth $409K as of Q1 2026.
  • Moneta Group Investment Advisors bought 3 Labcorp shares in Q1 2026, an estimated $812.
  • Labcorp made up ﹤0.01% of Moneta Group Investment Advisors's portfolio in Q1 2026, its #555 holding.
  • Moneta Group Investment Advisors first reported a position in Labcorp in Q1 2018 and has held it in 13 quarters since.
  • Moneta Group Investment Advisors's Labcorp position peaked at $1.48M in Q1 2024.
  • 1,032 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Moneta Group Investment Advisors's 13F filing for Q1 2026, filed 12 May 2026.